
        <!DOCTYPE html>
        <html>
        <head>
            <title>Biogen Inc. (BIIB) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Biogen Inc. (BIIB)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">← Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">50</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">20</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">10</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.13</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e046b348e8b493541df8ec3908ead5f338f8e0b210d5ab4aa581571dbe39b068" target="_blank" rel="noopener noreferrer">Q1 2025 Biogen Inc Earnings Call</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Q1 2025 Biogen Inc Earnings Call...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d94ccff3aa93d7c189e15c53ee7b47829e835119950ddf3f1de8d0a95f3d3311" target="_blank" rel="noopener noreferrer">Biogen Inc (BIIB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst MS Franchise ...</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.96
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc (BIIB) reports a 6% revenue increase driven by new product launches, despite facing competitive pressures in its MS franchise....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=242206166bfbd56bab1c6e3cfcd9bfea0b22e42ed5ab4f7339be18ab9bab7346" target="_blank" rel="noopener noreferrer">Biogen Emerging as 'Leaner, Less Risky' Company, RBC Says</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-02</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) seems to be emerging as a "leaner" and "less risky" company, RBC Capital Markets said...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=57da73229c5561ea6fd90f4bf9e4d22ab534210acd7721ecc6e8f921b1f8ed6f" target="_blank" rel="noopener noreferrer">Biogen beats quarterly profit estimates on strong demand for rare disease drugs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen beat first-quarterprofit and revenue expectations on Thursday, as strong demandfor its rare disease drugs helped offset declining sales of itsmultiple sclerosis drugs. The......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=88b0ab958cf229538cb25488ee65f7a4de235811392584baf09b369d99f37d8a" target="_blank" rel="noopener noreferrer">Biogen : Q1 2025 Biogen Earnings Presentation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">May 1, 2025 FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATE ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=cbc8f64a07eb58e1e6a7e4d9042a524a36dc30e5c54a98e71b612e0c4eabbcf8" target="_blank" rel="noopener noreferrer">Biogen : Q125 Earnings Presentation FINAL</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">May 1, 2025 FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS UPDATE ......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=999d8e556cfc0a3b4d5f1112f0f51fa93ff02a792c65a44df7b6dad17bd51f26" target="_blank" rel="noopener noreferrer">Biogen Inc. 2025 Q1 - Results - Earnings Call Presentation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The following slide deck was published by Biogen Inc....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=802125be565922c378d99b8fd2f2430dce4b0a40599a4e8ae7d2e7f23b3bbbbe" target="_blank" rel="noopener noreferrer">Biogen's results beat estimates on strength in rare disease drugs</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.91
                                </span>
                            </div>
                            <div class="article-summary">Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped offset declining sales of its multiple sclerosis medicines.  The drugmaker has...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b2fecc7cd0d6d42f570b23b6ce510a3dfcc073901767610f14979c30c1c53253" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Q1 2025 Earnings Call Transcript</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. (NASDAQ:BIIB) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsTim Power - Head, Investor RelationsChris Viehbacher -......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7255f8bddd7a5917e7e01fae044878be62cc33fa3085f5289ee35e4fcee1a35d" target="_blank" rel="noopener noreferrer">Biogen Inc. (BIIB) Q1 Earnings Lag Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.38
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) delivered earnings and revenue surprises of -7.36% and 8.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b208c788571192d005abd023059ebe86412ce4f392390c2f60f16617b2f26020" target="_blank" rel="noopener noreferrer">Biogen (NASDAQ:BIIB) Beats Q1 Sales Targets</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.94
                                </span>
                            </div>
                            <div class="article-summary">Biotech company Biogen (NASDAQ:BIIB) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 6.1% year on year to $2.43 billion. Its non-GAAP profit of $3.02 per share wa...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=eb6e68a2a05e9803f3e8735ed263d21a34f576591c9be286324c1297b535afd3" target="_blank" rel="noopener noreferrer">Is Biogen At The 'Start Of A Turnaround' On Its Quarterly Beat?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">Biogen stock traded sideways Thursday after the company beat first-quarter expectations, including strong sales for two newcomer drugs....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d28d15ee3543c05313fccced8e705e7c716a3bf4e49c10a269ab79d8b8b1a234" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Although the revenue and EPS for Biogen (BIIB) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street e...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e2b3d48a1ebddff360d57d4d3923a8d30fb55b166c7b873bb437e8a749818df2" target="_blank" rel="noopener noreferrer">BIIB's Q1 Earnings Miss, Revenues Top Mark, 2025 EPS Guidance Cut</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">Biogen reports mixed first-quarter 2025 results. It also lowers its EPS guidance for the current year....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4b7831e1da55686da26245f432acc54c7492ed5170da956a76c41aaa303dd9c8" target="_blank" rel="noopener noreferrer">Biogen (NasdaqGS:BIIB) Reports Q1 Revenue Growth Despite Decline in Net Income</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.73
                                </span>
                            </div>
                            <div class="article-summary">Biogen (NasdaqGS:BIIB) reported a mixed financial performance with Q1 2025 earnings illustrating a decline in net income and EPS compared to the prior year, while revenue saw an increase. This week's ...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4a248af94b0cc78aeff34580666ce67bd967c057c00af6d2f8228b16fb749953" target="_blank" rel="noopener noreferrer">Biogen’s Q1 revenue soars past estimates as rare disease pivot pays off</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">Biogen’s CEO Chris Vibacher said ‘a new Biogen’ is emerging following the end of its multiple sclerosis treatments heyday....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5f9be45e02582d49977c427f67ae9a3948f5d601fc8a1a3cbba14ccc10e97425" target="_blank" rel="noopener noreferrer">Biogen Earnings: What To Look For From BIIB</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biotech company Biogen (NASDAQ:BIIB) will be announcing earnings results tomorrow before the bell. Here’s what you need to know....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=df37a3bdcc30d38ac0ebb848a6b12e32f5fea438f95007e17a3b8b7444b63a8f" target="_blank" rel="noopener noreferrer">Q1 2025 SAGE Therapeutics Inc Earnings Call</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Q1 2025 SAGE Therapeutics Inc Earnings Call...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aeb75217d6d17bee63569b6d529993080e2e632932c4746fe0f7cd70a6817ca0" target="_blank" rel="noopener noreferrer">Unveiling Biogen (BIIB) Q1 Outlook: Wall Street Estimates for Key Metrics</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Get a deeper insight into the potential performance of Biogen (BIIB) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some ...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e37a5b855ceab8b0bc7454b0a520108fcd17bc2ed8f44e5190108c2617256531" target="_blank" rel="noopener noreferrer">Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.01
                                </span>
                            </div>
                            <div class="article-summary">SAGE's earnings and revenues miss estimates in the first quarter of 2025. The company focuses on the commercialization of its depression drug Zurzuvae....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=10267bcd617e23ba8d8bbe1750438e8430eb148f8aec20cc5072b67f5cf345c9" target="_blank" rel="noopener noreferrer">Biogen Inc. (NASDAQ:BIIB) is largely controlled by institutional shareholders who own 90% of the company</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Key Insights Significantly high institutional ownership implies Biogen's stock price is sensitive to their trading......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b533d00f3cfcfab75996e6f61bdb4111f0bc92aa9dbf9d909f8cdf7ce7accfce" target="_blank" rel="noopener noreferrer">The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pfizer, Eli Lilly, Amgen, Biogen and Regeneron are included in this Analyst Blog....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=062e71da293e5acdf59c75930df11761dbed49206a40463aa55cc33e5365d323" target="_blank" rel="noopener noreferrer">Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ef3adb4bcd126997d1f1592527ecb2afc521115bd3cda32b4212595c2984fefe" target="_blank" rel="noopener noreferrer">Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-25</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Biogenâs lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a084d6263b0c09485db547c8ac16c272932baf5d5b04cc25de07625a337bf916" target="_blank" rel="noopener noreferrer">Biogen’s Friedreich’s ataxia treatment authorised in UK</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.56
                                </span>
                            </div>
                            <div class="article-summary">In a trial, patients showed neurological improvement when treated with the therapy versus a placebo....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=65fc240d9312ba1e919a2ce748d1b1e99cc78c13c98dce06d3c78cddb24fc76c" target="_blank" rel="noopener noreferrer">Can Biogen Keep the Beat Streak Alive This Earnings Season?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.53
                                </span>
                            </div>
                            <div class="article-summary">In the first quarter, lower sales of BIIB's multiple sclerosis drugs are likely to have been offset by revenues from new drugs....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=65d111117ef81977a5e2f1c6a65fc502b06f9198071ba1cf602067871337f41d" target="_blank" rel="noopener noreferrer">1 Safe-and-Steady Stock with Promising Prospects and 2 to Ignore</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.31
                                </span>
                            </div>
                            <div class="article-summary">Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2d0eabef8e5fcead7d3b1014dd40ec9f019ab431ffe9d3c772d110a8ceabfbd8" target="_blank" rel="noopener noreferrer">Earnings Preview: Biogen Inc. (BIIB) Q1 Earnings Expected to Decline</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.38
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=640770852be4055005b2f6e8b381175ad22d6a6aecc41ce23e85a36aff4be17e" target="_blank" rel="noopener noreferrer">Biogen Inc. stock rises Thursday, still underperforms market</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-24</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.64
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock rises Thursday, still underperforms market...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=52a1a665234cc228e40538d3ac33ea84790685e98aca74a98367db20746889ce" target="_blank" rel="noopener noreferrer">Biogen Inc. stock rises Tuesday, still underperforms market</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-22</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.72
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock rises Tuesday, still underperforms market...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a91bb94b14a40482e8dd6401fc256d758b43096a1be62885e6a43256a3a25a67" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Monday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-21</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Monday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=94a1da4effa3fd9dbcf72ac97a87f782f5b9a3cfcce4408eb37a2738f415f516" target="_blank" rel="noopener noreferrer">Scholar Rock: Apitegromab Approval And Obesity Shot Make For Rating Upgrade</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-17</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.36
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bdfd2130d40d7e82b4bedb4646486ba08ef1b6de87a6e3a19cab63b4dc244f9c" target="_blank" rel="noopener noreferrer">Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-16</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early AD) wh...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5628000ce90451ad3feba63dc3921af7e60038a76d85ce0805109cef259256cc" target="_blank" rel="noopener noreferrer">EC authorises Eisai and Biogen’s lecanemab for Alzheimer’s</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-16</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.43
                                </span>
                            </div>
                            <div class="article-summary">The antibody is now approved for treating adults diagnosed with mild cognitive impairment and mild dementia....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=783f56df13b7dc5876faba6bdbf3b2c9c3036249e20be83de1a1eea8cc2b3dc3" target="_blank" rel="noopener noreferrer">Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-16</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.65
                                </span>
                            </div>
                            <div class="article-summary">Following the nod in the EU, BIIB & Eisai's Leqembi becomes the first therapy to slow the progression of early Alzheimer's disease in the region....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7e68c3db43366af2f0c6b1490606de6889a3376750b52d2a483f1de5757574ae" target="_blank" rel="noopener noreferrer">Biogen : European Commission Grants Marketing Authorization for Leqembi® (lecanemab)</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.83
                                </span>
                            </div>
                            <div class="article-summary">The European Commission has granted the amyloid-beta monoclonal antibody Leqembi® Marketing Authorization in the European Union . Lecanemab is indicated for the treatment of adult patients with a......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=189521f405d9025be1efe40ce70a709c746197ccfff3cbf7206877904998a8f5" target="_blank" rel="noopener noreferrer">EU authorizes Eisai-Biogen's drug for early Alzheimer's treatment</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.50
                                </span>
                            </div>
                            <div class="article-summary">The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0137e7da1ab3cf6d2dd3df655416d488d666c5e41e7dc70bee45323ab4427c8b" target="_blank" rel="noopener noreferrer">Drug to Treat Underlying Causes of Alzheimer's Gets EU Marketing Approval</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-15</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.69
                                </span>
                            </div>
                            <div class="article-summary">By Connor Hart A drug that targets an underlying cause of Alzheimer's disease being commercialized by Eisai and Biogen has received marketing approval from the European Commission. The......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=5114922ae4f0909b09f02f693f79099485ab862a35421bf5b9c7126c72432cb1" target="_blank" rel="noopener noreferrer">Biogen : Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-14</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease by the European Commission TOKYO and CAMBRIDGE, Mass., April 14, 2025 - Eisai Co., Ltd. and Biogen Inc. ......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1ff53d573cbcff781b0ba18c35b9676ab11410e48893de962d0c22d56fcca358" target="_blank" rel="noopener noreferrer">Alzheon’s Alzheimer’s pill fails in Phase III trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-11</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.24
                                </span>
                            </div>
                            <div class="article-summary">The drug showed nominal benefit in a subgroup of patients who suffer with mild cognitive impairment....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d7ed624044a165ef9e4f90ed98a5ca13b641b58b3a3ee802a806a6969c4982fc" target="_blank" rel="noopener noreferrer">Pharma Tariffs Are Coming. Investors Underestimate the Risk.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-11</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Pharma Tariffs Are Coming. Investors Underestimate the Risk....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b795cd3c561cb6f6acc43dc325778761f03e38af4d74e495bbc388bffa328cf6" target="_blank" rel="noopener noreferrer">Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.23
                                </span>
                            </div>
                            <div class="article-summary">Biogen (BIIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=ebe2fe3863e452ce1f401d2c50f1387550a453d0542dbec5a3f279f530e924c4" target="_blank" rel="noopener noreferrer">Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-10</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Robert F. Kennedy Jr. is the new Health Secretary. From fluoride, vaccines and beef tallow, here's how he might "go wild" on biotech stocks....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=463b4dc6d1d5cc98cb8238b60c43144a886bf56b84323122e66413b033e31539" target="_blank" rel="noopener noreferrer">Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-09</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=decf95059ecf3b0a14682162a2c5a8837dafd88f0d797986244d8d40193b043b" target="_blank" rel="noopener noreferrer">Biogen Inc. stock rises Wednesday, still underperforms market</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-09</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment positive">
                                    0.63
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock rises Wednesday, still underperforms market...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e63892e7a791faa93da005997d66ac8df4fdfcb3851e6d722a9f0a524a2beb0d" target="_blank" rel="noopener noreferrer">Sage Therapeutics: A Speculative Play That Needs To Wait For A Turnaround Story</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-09</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment negative">
                                    -0.52
                                </span>
                            </div>
                            <div class="article-summary">Sage Therapeutics faces challenges with a 90% value drop but shows promise with Zurzuvae for postpartum depression. Click here to read my most recent analysis on SAGE....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b910c0de5e2f9663213c2dc2f5353baebe04a074d4c9f4686ab9cb79435368cd" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Tuesday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-08</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Tuesday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b811b96fb0ab108b044f377892b6160f10c437e1a83a90fa3038545190bf80bf" target="_blank" rel="noopener noreferrer">Biogen Inc. stock underperforms Friday when compared to competitors</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-04</span>
                                <span>MarketWatch</span>
                                <span class="article-sentiment negative">
                                    -0.90
                                </span>
                            </div>
                            <div class="article-summary">Biogen Inc. stock underperforms Friday when compared to competitors...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=45f13dc2652f61e0ea1627320908e91a237ee432e708856e48db630703054bfe" target="_blank" rel="noopener noreferrer">BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.83
                                </span>
                            </div>
                            <div class="article-summary">The FDA's fast track designation will facilitate rapid development and expedited review of Biogen's Alzheimer's disease candidate....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=54285916685749cb2be53f7df0c4e859dfec354e0fce8e5b4bebec6302d6ab58" target="_blank" rel="noopener noreferrer">Biogen (NasdaqGS:BIIB) Gets US FDA Fast Track For Alzheimer's Despite US$8M Settlement</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-04-03</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.11
                                </span>
                            </div>
                            <div class="article-summary">Biogen (NasdaqGS:BIIB) recently received Fast Track designation from the FDA for its Alzheimer's therapy, BIIB080, signaling a significant advancement in its drug development ambitions. However, despi...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        